Literature DB >> 15653373

Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review.

Isabel P Neuringer1, Worakij Chalermskulrat, Robert Aris.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15653373     DOI： 10.1016/j.healun.2004.01.009

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  12 in total

1.  Compartmentalization of intracellular proinflammatory cytokines in bronchial intraepithelial T cells of stable lung transplant patients.

Authors:  G Hodge; S Hodge; P N Reynolds; M Holmes
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

Review 2.  Novel insights into lung transplant rejection by microarray analysis.

Authors:  Jeffrey D Lande; Jagadish Patil; Na Li; Todd R Berryman; Richard A King; Marshall I Hertz
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Authors:  Cassandra L Mikols; Le Yan; Jin Y Norris; Tonya D Russell; Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Mario Castro; Elbert Kuo; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

5.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

6.  Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.

Authors:  W Chalermskulrat; K P McKinnon; W J Brickey; I P Neuringer; R C Park; D G Sterka; B R Long; P McNeillie; R J Noelle; J P Ting; R M Aris
Journal:  Thorax       Date:  2005-10-27       Impact factor: 9.139

7.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

8.  Interstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipients.

Authors:  Andrew D Mihalek; Ivan O Rosas; Robert F Padera; Anne L Fuhlbrigge; Gary M Hunninghake; Dawn L DeMeo; Phillip C Camp; Hilary J Goldberg
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 9.  Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.

Authors:  Jason W Chien; Steven Duncan; Kirsten M Williams; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-05       Impact factor: 5.742

Review 10.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.